Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Joaquin Mateo


Joaquin Mateo

Vall d’Hebron Institute of Oncology


Joaquin Mateo received his MD from the University of Barcelona in 2006. After completing his medical training in Oncology at the Catalan Institute of Oncology (Barcelona), he completed postgraduate studies in clinical trial design, with special interest for early-phase clinical trials with companion biomarker development.

He joined the Drug Development Unit at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research (London) in 2011 for a two-year fellowship under the mentorship of Prof Johann de Bono and Prof Stan Kaye, working in first-in-man clinical trials of several PARP inhibitors and compounds targeting the PI3K-AKT-mTOR pathway. From 2013, he progressively focused his work towards the design and development of clinical trials for castration-resistant prostate cancer (CRPC).

His main interest is the integration of tumour molecular characterisation data into real-time clinical decision-making for patients through multidisciplinary tumour boards, and has been involved in the set up of molecular tumour boards at the Drug Development Unit and Prostate Cancer Targeted Therapy Unit at The Royal Marsden.

After receiving a joint Medical Research Council & Prostate Cancer UK Fellowship award in 2014, he is currently pursuing a PhD at The Institute of Cancer Research (London); the focus of his research is to better understand the prevalence and clinical relevance of germline and somatic DNA repair defects in the progression of prostate cancer and how to therapeutically exploit these aberrations. In 2016, he received a Prostate Cancer Foundation Young Investigator Award to continue working in the development of PARP inhibitors, platinum-based therapies and companion predictive biomarkers for CRPC patients.

Last update: April 2017

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.